BIOVIA

Digital Lab Documentation

Life Sciences organizations need to bring new high-quality therapeutics to market fast to respond to patient needs specific to different diseases and geographies. But development time and costs for new therapeutics are gigantic with an average accrual of $2.6B and 12 years from ideation to market. Reasons for the struggle include (1) the long “time to fail” in new target identification, (2) increasing global and regional regulations and scrutiny, and (3) the major efforts required to ensure that therapeutics are safe, efficacious and compliant with specifications. Personalized Medicine and Patient Centricity add complexity to Development and Manufacturing. Testing is required to confirm therapeutic characteristics discovered during Research, to identify and optimize formulations for production and scale-up, and to release active ingredients and products. Download the White Paper now.

Accelerate Digital Transformation

Life Science companies face major challenges to continued operations and profitability from patent expirations, low R&D productivity, increased competition, decreased margins, inefficient processes, and mounting compliance constraints. To meet these challenges, life sciences companies are focusing on digital transformation with a view to improving collaboration across their business, particularly in R&D activities. Scientists run hundreds of experiments, but they often lack a clearly defined way of sharing information and knowledge between individuals and teams. They document information either in paper notebooks or disparate electronic systems, and often lack a centralized database to capture, store and share critical experimental results and other product information. Get the Use Case

How To Manage Compliance in a Global Media Device Company

This medical device company develops, manufactures and markets critical customer care products worldwide. To improve the efficiency of company offices, manufacturing facilities and distribution centers around the world, the company approached Dassault Systèmes to assist them in better integrating the common elements of compliance including content, processes, people and systems across the organization. Get the Use Case

The 21st Century Lab

Life Science companies face major challenges to continued operations and profitability from patent expirations, low R&D productivity, increased competition, decreased margins, inefficient processes, and mounting compliance constraints. Get the eBook now